Author

Gisela Nogales‐Gadea

Universitat Autònoma de BarcelonaORCID 0000-0002-7414-212XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Assay:multiome· 1 Assay:organoid / primary culture· 1

Frequent Co-Authors

Anne BigotiD· 2 shared Kamel MamchaouiiD· 2 shared A.A. أحمد علاء الدين طه Al-AniiD· 1 shared Adolfo López de MunainiD· 1 shared Ainoa Tejedera‐VillafrancaiD· 1 shared Andrea López‐MartíneziD· 1 shared Javier Ramón‐AzcóniD· 1 shared Juan M. Fernández‐CostaiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioengineering

Anne BigotORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BioengineeringbioRxivPreprintFeb 5, 2026

Patient-derived 3D engineered human muscle model recapitulates CLCN1 mis-splicing and myotonia in myotonic dystrophy type 1

Xiomara Fernández‐Garibay, María Sabater-Arcis, Ainoa Tejedera‐Villafranca…·Juan M. Fernández‐Costa

This paper develops a 3D human muscle model from DM1 patient myoblasts that recapitulates CLCN1 mis-splicing and myotonia, and tests therapeutic responses.

DOI 10.64898/2026.02.03.703003

humanorganoid / primary culture

𝕏 PostBluesky

Cell BiologyNAR Molecular MedicinePeer-reviewedJun 20, 2025

Characterisation of DMPK and MBNL1 expression in cell models of Myotonic Dystrophy: A platform for drug screening

Andrea López‐Martínez, Sergio Martín‐González, Noemi Torres‐Conde…·Virginia Arechavala‐Gomeza

This paper develops a cell-based platform to quantify DMPK and MBNL1 in DM1 models and evaluates therapeutic strategies targeting DMPK.

1 citation

humanproteomics

𝕏 PostBluesky